Price Alert: Shares of IVERIC bio (ISEE) Trade 9.26% Higher at Midday August 5

Equities Staff  |

IVERIC bio Inc (NASDAQ: ISEE) shares climbed 9.26%, or $1.06 per share, as on 11:58:47 est today. Opening the day at $11.80, 962,732 shares of IVERIC bio exchanged hands and the stock has ranged between $12.70 and $11.56.  

So far this year the company has moved YTD 27.45%.

IVERIC bio expects its next earnings on 2022-11-01.

For technical charts, analysis, and more on IVERIC bio visit the company profile.

About IVERIC bio Inc

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.

To get more information on IVERIC bio Inc and to follow the company's latest updates, you can visit the company's profile page here: IVERIC bio Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan



Market Movers

Sponsored Financial Content